333 related articles for article (PubMed ID: 23540744)
1. Strategies to prevent and treat cardiovascular risk in cancer patients.
Cardinale D; Bacchiani G; Beggiato M; Colombo A; Cipolla CM
Semin Oncol; 2013 Apr; 40(2):186-98. PubMed ID: 23540744
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced cardiotoxicity: detection, prevention, and management.
Truong J; Yan AT; Cramarossa G; Chan KK
Can J Cardiol; 2014 Aug; 30(8):869-78. PubMed ID: 25064580
[TBL] [Abstract][Full Text] [Related]
3. Using cardiac biomarkers and treating cardiotoxicity in cancer.
Colombo A; Cardinale D
Future Cardiol; 2013 Jan; 9(1):105-18. PubMed ID: 23259478
[TBL] [Abstract][Full Text] [Related]
4. Therapy insight: Management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy.
Khakoo AY; Yeh ET
Nat Clin Pract Oncol; 2008 Nov; 5(11):655-67. PubMed ID: 18797437
[TBL] [Abstract][Full Text] [Related]
5. Role of biomarkers in chemotherapy-induced cardiotoxicity.
Cardinale D; Sandri MT
Prog Cardiovasc Dis; 2010; 53(2):121-9. PubMed ID: 20728699
[TBL] [Abstract][Full Text] [Related]
6. [Cardioprotection in women with neoplastic disease].
Cardinale D; Colombo A; Bacchiani G
G Ital Cardiol (Rome); 2012 Jun; 13(6):461-8. PubMed ID: 22622126
[TBL] [Abstract][Full Text] [Related]
7. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
[TBL] [Abstract][Full Text] [Related]
8. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.
Albini A; Pennesi G; Donatelli F; Cammarota R; De Flora S; Noonan DM
J Natl Cancer Inst; 2010 Jan; 102(1):14-25. PubMed ID: 20007921
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of cancer-therapy-induced cardiotoxicity: introducing microRNA biomarkers for early assessment of subclinical myocardial injury.
Sandhu H; Maddock H
Clin Sci (Lond); 2014 Mar; 126(6):377-400. PubMed ID: 24274966
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.
Yeh ET; Bickford CL
J Am Coll Cardiol; 2009 Jun; 53(24):2231-47. PubMed ID: 19520246
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxicity associated with cancer therapy: pathophysiology and prevention strategies.
Adão R; de Keulenaer G; Leite-Moreira A; Brás-Silva C
Rev Port Cardiol; 2013 May; 32(5):395-409. PubMed ID: 23623503
[TBL] [Abstract][Full Text] [Related]
12. Curing Cancer, Saving the Heart: A Challenge That Cardioncology Should Not Miss.
Cardinale D; Biasillo G; Cipolla CM
Curr Cardiol Rep; 2016 Jun; 18(6):51. PubMed ID: 27108361
[TBL] [Abstract][Full Text] [Related]
13. Cardiotoxicity associated with trastuzumab treatment of HER2+ breast cancer.
Fiúza M
Adv Ther; 2009 Jul; 26 Suppl 1():S9-17. PubMed ID: 19669637
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
Yeh ET; Tong AT; Lenihan DJ; Yusuf SW; Swafford J; Champion C; Durand JB; Gibbs H; Zafarmand AA; Ewer MS
Circulation; 2004 Jun; 109(25):3122-31. PubMed ID: 15226229
[TBL] [Abstract][Full Text] [Related]
15. Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors.
Steingart RM; Bakris GL; Chen HX; Chen MH; Force T; Ivy SP; Leier CV; Liu G; Lenihan D; Lindenfeld J; Maitland ML; Remick SC; Tang WH
Am Heart J; 2012 Feb; 163(2):156-63. PubMed ID: 22305831
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of cardiomyopathy and heart failure in patients receiving cancer chemotherapy.
Cardinale D; Colombo A; Cipolla CM
Curr Treat Options Cardiovasc Med; 2008 Dec; 10(6):486-95. PubMed ID: 19026179
[TBL] [Abstract][Full Text] [Related]
17. Cardiac Outcomes in Survivors of Pediatric and Adult Cancers.
Nathan PC; Amir E; Abdel-Qadir H
Can J Cardiol; 2016 Jul; 32(7):871-80. PubMed ID: 27179545
[TBL] [Abstract][Full Text] [Related]
18. Cancer drugs and the heart: importance and management.
Suter TM; Ewer MS
Eur Heart J; 2013 Apr; 34(15):1102-11. PubMed ID: 22789916
[TBL] [Abstract][Full Text] [Related]
19. Predicting and preventing the cardiotoxicity of cancer therapy.
Anderson B; Sawyer DB
Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):1023-33. PubMed ID: 18666852
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular toxicities of biological therapies.
Ryberg M
Semin Oncol; 2013 Apr; 40(2):168-77. PubMed ID: 23540742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
